In 2008, a review by Tai and Tang introduced in detail the role of SPARC in cancer progression and its potential for cancer therapy, and the role of SPARC in sensitizing therapy-resistant cancer types was also discussed (Tai and Tang, 2008). Here, SPARC is linked to cancer.